3) were all better for covered stents for the
treatment of the primary lesions. Similarly, they reported
that the freedom from restenosis (89 6 10% vs 49 6 14%;
P < .04), freedom from symptom recurrence (100% vs
64 6 9%; P Â¼ .001), and freedom from reintervention
(100% vs 72 6 